Back to all firms
SUPN
Supernus Pharmaceuticals, Inc.
Tracked Holders (1)
| Manager | % of Portfolio | Activity | Shares | Value | Period |
|---|---|---|---|---|---|
| Third Avenue Management | 1.71% | — | 189.5K | $9.4M | Q4 2025 |